“Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.”, Science, vol. 341, no. 6152, pp. 1359-65, 2013.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
,